2020-2025 Global Checkpoint Inhibitors For Treating Cancer Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

August 2021 | 103 pages | ID: 2218BB111733EN
Maia Research

Abstracts

Checkpoint inhibitor is a type of drug used in immunotherapy, which helps block the proteins present on tumor cells, as these affect the functioning of the immune system. Immune checkpoint inhibitor drugs block different checkpoint proteins, including cytotoxic T lymphocyte associated protein 4 (CTLA-4), programmed cell death protein (PD-1), and programmed death ligand 1 (PD-L1). Immune checkpoint inhibitors have witnessed increasing demand, owing to increase in incidence of different forms of cancer, surge in awareness of checkpoint inhibitors for the treatment of cancer, higher number of pipeline drugs, and upsurge in adoption of immune checkpoint inhibitor drugs.
This report elaborates the market size, market characteristics, and market growth of the Checkpoint Inhibitors For Treating Cancer industry, and breaks down according to the type, application, and consumption area of Checkpoint Inhibitors For Treating Cancer. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Checkpoint Inhibitors For Treating Cancer in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Checkpoint Inhibitors For Treating Cancer market covered in Chapter 13:
CTLA-4 Inhibitors
PD-L1 Inhibitors
Bristol-Myers Squibb(BMS)
Merck
PD-1 Inhibitors
Roche

In Chapter 6, on the basis of types, the Checkpoint Inhibitors For Treating Cancer market from 2015 to 2025 is primarily split into:
CTLA-4 inhibitors
PD-L1 inhibitors
PD-1 inhibitors

In Chapter 7, on the basis of applications, the Checkpoint Inhibitors For Treating Cancer market from 2015 to 2025 covers:
Bladder cancer treatment
Melanoma treatment
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - RESEARCH SCOPE

1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - RESEARCH METHODOLOGY

2.1 Methodology
2.2 Research Data Source
  2.2.1 Secondary Data
  2.2.2 Primary Data
  2.2.3 Market Size Estimation
  2.2.4 Legal Disclaimer

3 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET FORCES

3.1 Global Checkpoint Inhibitors For Treating Cancer Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
  3.2.1 Political Factors
  3.2.2 Economic Factors
  3.2.3 Social Factors
  3.2.4 Technological Factors
  3.2.5 Environmental Factors
  3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
  3.4.1 Risk Assessment on COVID-19
  3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
  3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - BY GEOGRAPHY

4.1 Global Checkpoint Inhibitors For Treating Cancer Market Value and Market Share by Regions
  4.1.1 Global Checkpoint Inhibitors For Treating Cancer Value ($) by Region (2015-2020)
  4.1.2 Global Checkpoint Inhibitors For Treating Cancer Value Market Share by Regions (2015-2020)
4.2 Global Checkpoint Inhibitors For Treating Cancer Market Production and Market Share by Major Countries
  4.2.1 Global Checkpoint Inhibitors For Treating Cancer Production by Major Countries (2015-2020)
  4.2.2 Global Checkpoint Inhibitors For Treating Cancer Production Market Share by Major Countries (2015-2020)
4.3 Global Checkpoint Inhibitors For Treating Cancer Market Consumption and Market Share by Regions
  4.3.1 Global Checkpoint Inhibitors For Treating Cancer Consumption by Regions (2015-2020)
  4.3.2 Global Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Regions (2015-2020)

5 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - BY TRADE STATISTICS

5.1 Global Checkpoint Inhibitors For Treating Cancer Export and Import
5.2 United States Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
5.3 Europe Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
5.4 China Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
5.5 Japan Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
5.6 India Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
5.7 ...

6 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - BY TYPE

6.1 Global Checkpoint Inhibitors For Treating Cancer Production and Market Share by Types (2015-2020)
  6.1.1 Global Checkpoint Inhibitors For Treating Cancer Production by Types (2015-2020)
  6.1.2 Global Checkpoint Inhibitors For Treating Cancer Production Market Share by Types (2015-2020)
6.2 Global Checkpoint Inhibitors For Treating Cancer Value and Market Share by Types (2015-2020)
  6.2.1 Global Checkpoint Inhibitors For Treating Cancer Value by Types (2015-2020)
  6.2.2 Global Checkpoint Inhibitors For Treating Cancer Value Market Share by Types (2015-2020)
6.3 Global Checkpoint Inhibitors For Treating Cancer Production, Price and Growth Rate of CTLA-4 inhibitors (2015-2020)
6.4 Global Checkpoint Inhibitors For Treating Cancer Production, Price and Growth Rate of PD-L1 inhibitors (2015-2020)
6.5 Global Checkpoint Inhibitors For Treating Cancer Production, Price and Growth Rate of PD-1 inhibitors (2015-2020)

7 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET - BY APPLICATION

7.1 Global Checkpoint Inhibitors For Treating Cancer Consumption and Market Share by Applications (2015-2020)
  7.1.1 Global Checkpoint Inhibitors For Treating Cancer Consumption by Applications (2015-2020)
  7.1.2 Global Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Applications (2015-2020)
7.2 Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate of Bladder cancer treatment (2015-2020)
7.3 Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate of Melanoma treatment (2015-2020)
7.4 Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate of Others (2015-2020)

8 NORTH AMERICA CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET

8.1 North America Checkpoint Inhibitors For Treating Cancer Market Size
8.2 United States Checkpoint Inhibitors For Treating Cancer Market Size
8.3 Canada Checkpoint Inhibitors For Treating Cancer Market Size
8.4 Mexico Checkpoint Inhibitors For Treating Cancer Market Size
8.5 The Influence of COVID-19 on North America Market

9 EUROPE CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET ANALYSIS

9.1 Europe Checkpoint Inhibitors For Treating Cancer Market Size
9.2 Germany Checkpoint Inhibitors For Treating Cancer Market Size
9.3 United Kingdom Checkpoint Inhibitors For Treating Cancer Market Size
9.4 France Checkpoint Inhibitors For Treating Cancer Market Size
9.5 Italy Checkpoint Inhibitors For Treating Cancer Market Size
9.6 Spain Checkpoint Inhibitors For Treating Cancer Market Size
9.7 The Influence of COVID-19 on Europe Market

10 ASIA-PACIFIC CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET ANALYSIS

10.1 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Market Size
10.2 China Checkpoint Inhibitors For Treating Cancer Market Size
10.3 Japan Checkpoint Inhibitors For Treating Cancer Market Size
10.4 South Korea Checkpoint Inhibitors For Treating Cancer Market Size
10.5 Southeast Asia Checkpoint Inhibitors For Treating Cancer Market Size
10.6 India Checkpoint Inhibitors For Treating Cancer Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 MIDDLE EAST AND AFRICA CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET ANALYSIS

11.1 Middle East and Africa Checkpoint Inhibitors For Treating Cancer Market Size
11.2 Saudi Arabia Checkpoint Inhibitors For Treating Cancer Market Size
11.3 UAE Checkpoint Inhibitors For Treating Cancer Market Size
11.4 South Africa Checkpoint Inhibitors For Treating Cancer Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 SOUTH AMERICA CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET ANALYSIS

12.1 South America Checkpoint Inhibitors For Treating Cancer Market Size
12.2 Brazil Checkpoint Inhibitors For Treating Cancer Market Size
12.3 The Influence of COVID-19 on South America Market

13 COMPANY PROFILES

13.1 CTLA-4 Inhibitors
  13.1.1 CTLA-4 Inhibitors Basic Information
  13.1.2 CTLA-4 Inhibitors Product Profiles, Application and Specification
  13.1.3 CTLA-4 Inhibitors Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)
13.2 PD-L1 Inhibitors
  13.2.1 PD-L1 Inhibitors Basic Information
  13.2.2 PD-L1 Inhibitors Product Profiles, Application and Specification
  13.2.3 PD-L1 Inhibitors Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)
13.3 Bristol-Myers Squibb(BMS)
  13.3.1 Bristol-Myers Squibb(BMS) Basic Information
  13.3.2 Bristol-Myers Squibb(BMS) Product Profiles, Application and Specification
  13.3.3 Bristol-Myers Squibb(BMS) Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)
13.4 Merck
  13.4.1 Merck Basic Information
  13.4.2 Merck Product Profiles, Application and Specification
  13.4.3 Merck Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)
13.5 PD-1 Inhibitors
  13.5.1 PD-1 Inhibitors Basic Information
  13.5.2 PD-1 Inhibitors Product Profiles, Application and Specification
  13.5.3 PD-1 Inhibitors Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)
13.6 Roche
  13.6.1 Roche Basic Information
  13.6.2 Roche Product Profiles, Application and Specification
  13.6.3 Roche Checkpoint Inhibitors For Treating Cancer Market Performance (2015-2020)

14 MARKET FORECAST - BY REGIONS

14.1 North America Checkpoint Inhibitors For Treating Cancer Market Forecast (2020-2025)
14.2 Europe Checkpoint Inhibitors For Treating Cancer Market Forecast (2020-2025)
14.3 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Market Forecast (2020-2025)
14.4 Middle East and Africa Checkpoint Inhibitors For Treating Cancer Market Forecast (2020-2025)
14.5 South America Checkpoint Inhibitors For Treating Cancer Market Forecast (2020-2025)

15 MARKET FORECAST - BY TYPE AND APPLICATIONS

15.1 Global Checkpoint Inhibitors For Treating Cancer Market Forecast by Types (2020-2025)
  15.1.1 Global Checkpoint Inhibitors For Treating Cancer Market Forecast Production and Market Share by Types (2020-2025)
  15.1.2 Global Checkpoint Inhibitors For Treating Cancer Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Checkpoint Inhibitors For Treating Cancer Market Forecast by Applications (2020-2025)

List Of Tables

LIST OF TABLES AND FIGURES

Figure Checkpoint Inhibitors For Treating Cancer Picture
Table Checkpoint Inhibitors For Treating Cancer Key Market Segments
Figure Study and Forecasting Years
Figure Global Checkpoint Inhibitors For Treating Cancer Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Checkpoint Inhibitors For Treating Cancer Value ($) and Growth Rate (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Value ($) by Countries (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Value Market Share by Regions (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Value Market Share by Regions in 2019
Figure Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Production by Major Countries (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Production Market Share by Major Countries (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Production Market Share by Regions in 2019
Figure Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption by Regions (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Regions (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Regions in 2019
Table Global Checkpoint Inhibitors For Treating Cancer Export Top 3 Country 2019
Table Global Checkpoint Inhibitors For Treating Cancer Import Top 3 Country 2019
Table United States Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
Table China Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
Table Japan Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
Table India Checkpoint Inhibitors For Treating Cancer Export and Import (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Production by Types (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Production Market Share by Types (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Production Share by Type (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Value by Types (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Value Market Share by Types (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Value Share by Type (2015-2020)
Figure Global CTLA-4 inhibitors Production and Growth Rate (2015-2020)
Figure Global CTLA-4 inhibitors Price (2015-2020)
Figure Global PD-L1 inhibitors Production and Growth Rate (2015-2020)
Figure Global PD-L1 inhibitors Price (2015-2020)
Figure Global PD-1 inhibitors Production and Growth Rate (2015-2020)
Figure Global PD-1 inhibitors Price (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption by Applications (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Applications (2015-2020)
Figure Global Checkpoint Inhibitors For Treating Cancer Consumption Share by Application (2015-2020)
Figure Global Bladder cancer treatment Consumption and Growth Rate (2015-2020)
Figure Global Melanoma treatment Consumption and Growth Rate (2015-2020)
Figure Global Others Consumption and Growth Rate (2015-2020)
Figure North America Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Consumption by Countries (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure North America Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure United States Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Canada Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Mexico Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption by Countries (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Europe Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Germany Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure France Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Italy Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Spain Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption by Countries (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure China Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Japan Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure South Korea Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure India Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Checkpoint Inhibitors For Treating Cancer Consumption by Countries (2015-2020)
Table Middle East and Africa Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure UAE Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure South Africa Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Figure South America Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table South America Checkpoint Inhibitors For Treating Cancer Consumption by Countries (2015-2020)
Table South America Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure South America Checkpoint Inhibitors For Treating Cancer Consumption Market Share by Countries (2015-2020)
Figure Brazil Checkpoint Inhibitors For Treating Cancer Market Consumption and Growth Rate (2015-2020)
Table CTLA-4 Inhibitors Company Profile
Table CTLA-4 Inhibitors Production, Value, Price, Gross Margin 2015-2020
Figure CTLA-4 Inhibitors Production and Growth Rate
Figure CTLA-4 Inhibitors Value ($) Market Share 2015-2020
Table PD-L1 Inhibitors Company Profile
Table PD-L1 Inhibitors Production, Value, Price, Gross Margin 2015-2020
Figure PD-L1 Inhibitors Production and Growth Rate
Figure PD-L1 Inhibitors Value ($) Market Share 2015-2020
Table Bristol-Myers Squibb(BMS) Company Profile
Table Bristol-Myers Squibb(BMS) Production, Value, Price, Gross Margin 2015-2020
Figure Bristol-Myers Squibb(BMS) Production and Growth Rate
Figure Bristol-Myers Squibb(BMS) Value ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2015-2020
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table PD-1 Inhibitors Company Profile
Table PD-1 Inhibitors Production, Value, Price, Gross Margin 2015-2020
Figure PD-1 Inhibitors Production and Growth Rate
Figure PD-1 Inhibitors Value ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Production, Value, Price, Gross Margin 2015-2020
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Production by Types (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Production Share by Types (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Value ($) by Types (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Value Share by Types (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Consumption by Applications (2020-2025)
Table Global Checkpoint Inhibitors For Treating Cancer Market Forecast Consumption Share by Applications (2020-2025)